| AA | Amino acid |
| ABTS•+ | 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt radical cation |
| ACN | Acetonitrile |
| bLF | Bovin Lactoferrins |
| CC | Control cells |
| cLF | Camel lactoferrin |
| DMEM | Dulbecco’s modified Eagle’s medium |
| DMF | Dimethylformamide |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl radical |
| eLF | equine lactoferrin |
| ESI-IT MS | electrospray ionization-ion trap mass spectrometry |
| FBPs | Food-derived bioactive peptides |
| FBS | Fetal bovine serum |
| FRAP | ferric reducing antioxidant power |
| hLF | Human Lactoferrins |
| HPLC | High-performance liquid chromatography |
| IC50 | inhibit 50% of cell viability |
| LPS | Lipopolysaccharide |
| MDBPs | Milk-derived bioactive peptides |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide |
| NBT | Nitroblue tetrazolium |
| nhLF | Native human Lactoferrin |
| NMM | N-methylmorpholine |
| RAAS | Role in the renin–angiotensin–aldosterone system |
| rhLF | Recombinant human Lactoferrin |
| RIC50 | Relative Concentration To Reduce 50% |
| SD | Standard deviation |
| SPPS | Solid-phase peptide synthesis |
| TAS | Total antioxidant status |
| TFA | Trifluoroacetic acid |
| TIS | Triisopropylsilane |